Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Teva
 More »

  • Teva, Perrigo to Launch Generic Temodar
    Teva Pharmaceutical Industries and Perrigo said today they will launch a generic ... Teva said it will manufacture, market, and distribute the product in the United States, ...
    8-12-2013
  • Novo Nordisk Tops GEN List of Top 25 Biotech Companies
    Only two of the top 25 companies on this list-Teva (NYSE:TEVA) and Elan (NYSE:ELN)-saw their share prices decline, in each case following unique challenges that had many of the ...
    7-25-2013
  • Biosimilar Marriage Ends in Divorce for Teva, Lonza
    Teva Pharmaceutical Industries and Lonza Group said today they would end their ... and progress that the joint venture has made to this point," Teva said in a statement. ...
    7-25-2013
  • Rexahn Licenses University of Maryland Cancer Drug Delivery Platform
    linked to uncontrolled tumor growth; RX-3117, a small molecule compound developed with Teva Pharmaceutical Industries that inhibits DNA and RNA synthesis and induces apoptotic ...
    7-17-2013
  • Top 25 Biotech Companies of 2013
    Only two of the top 25 companies on this list (Teva and Elan) saw their share prices ... 49.5% Position on 2012 List: #8 #6. Teva Pharmaceutical Industries 2013 Market Cap: ...
    7-15-2013
  • Latest Biosimilar Guidance Raises More Questions
    ... FDA should also consider Teva Pharmaceuticals' advice to spell out how the agency will ... timelines for the various meetings," Teva stated in a letter from Penny S. Levin, ...
    6-21-2013
  • Teva Snaps Up MicroDose Therapeutx in Up To $165M Deal
    Teva Pharmaceutical Industries is acquiring MicroDose Therapeutx, a pharma and drug ... Teva is slated to acquire all of MicroDose's outstanding shares for $40 million, and will ...
    6-17-2013
  • Cancer's Bitter Medicine
    ... $118,000; Ariad Pharmaceuticals' ponatinib, $138,000; and Teva Pharmaceutical's Synribo (omacetaxine mepesuccinate), a monthly $28,000 for induction and $14,000 for maintenance. ...
    6-15-2013
  • Caution: Falling Job Zone
    ... And corporate cost-cutting goals-$2 billion at Teva; £1 billion (about $1.6 billion) annually through 2016 at GlaxoSmithKline-may bring pink slips to more employees yet. Even if ...
    6-14-2013
  • Pfizer Settles Teva, Sun Patent Infringement Case for $2.15B
    Pfizer just won a $2.15 billion settlement after a nearly 10-year battle with Teva ... Teva and Sun will pay a total of $2.15 billion to compensate Pfizer's subsidiary Wyeth (to ...
    6-13-2013
  • Cancer's Bitter Medicine
    ... $118,000; Ariad Pharmaceuticals' ponatinib, $138,000; and Teva Pharmaceutical's Synribo (omacetaxine mepesuccinate), a monthly $28,000 for induction and $14,000 for maintenance. ...
    5-21-2013
  • Companion Diagnostics: 52 Pick-Up
    ... Financial terms not disclosed. Myriad Genetics and Teva Pharmaceutical (Cephalon) Agreement announced March 28, 2012 Collaboration to test for BRCA1 and BRCA2 mutation via Myriad's ...
    5-9-2013
  • Biosimilars: 10 Drugs to Watch
    ... through acquisition of Insmed in 2009 Teva: Neugranin launch delayed in 2011, when ... Teva: Lipefilgrastin (XM22) meets primary endpoint in Phase III clinical trial of reducing ...
    4-22-2013
  • People in the News
    of clinical operations; and Henry Stern as executive director of CMC...Teva Pharmaceutical hired Ivana Magovcevic-Liebisch, Ph.D. , as svp, head of corporate business development. ...
    4-15-2013
  • Top 20 Biopharma R&D Spenders
    nearly all were either generics giants eager to develop portfolios of branded drugs (Teva), or biotechs looking to expand their product offerings (Gilead), or pharma giants ...
    4-1-2013

  • Journal Articles

  • Applications of Human Tissue-Engineered Blood Vessel Models to...
    Maria Pricci, Jean-Michel Bourget, Hubert Robitaille, Chiara Porro, Raffaella Soleti, H. Ahmed Mostefai, François A. Auger, M. Carmen Martinez, Ramaroson Andriantsitohaina, Lucie Germain
    Tissue Engineering, Part A
    The first two were composed of an adventitia (tissue-engineered vascular adventitia (TEVA)... affect superoxide anion (O2-) release in TEVA. MPs enhanced NF-?B expression but did not ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll